BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32164975)

  • 1. Drug repositioning for rare diseases: Knowledge-based success stories.
    Scherman D; Fetro C
    Therapie; 2020 Apr; 75(2):161-167. PubMed ID: 32164975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repositioning for orphan diseases.
    Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
    Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
    Brylinski M; Naderi M; Govindaraj RG; Lemoine J
    J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repurposing for Rare Diseases.
    Roessler HI; Knoers NVAM; van Haelst MM; van Haaften G
    Trends Pharmacol Sci; 2021 Apr; 42(4):255-267. PubMed ID: 33563480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico repositioning of approved drugs for rare and neglected diseases.
    Ekins S; Williams AJ; Krasowski MD; Freundlich JS
    Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases.
    Cuesta AM; Gallardo-Vara E; Casado-Vela J; Recio-Poveda L; Botella LM; Albiñana V
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases.
    Xu K; Coté TR
    Brief Bioinform; 2011 Jul; 12(4):341-5. PubMed ID: 21357612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.
    Pillaiyar T; Meenakshisundaram S; Manickam M; Sankaranarayanan M
    Eur J Med Chem; 2020 Jun; 195():112275. PubMed ID: 32283298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare Diseases: Drug Discovery and Informatics Resource.
    Zhao M; Wei DQ
    Interdiscip Sci; 2018 Mar; 10(1):195-204. PubMed ID: 29094320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseases.
    Micallef J; Blin O
    Therapie; 2020 Apr; 75(2):133-139. PubMed ID: 32156423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology.
    Micallef J; Boutouyrie P; Blin O
    Fundam Clin Pharmacol; 2017 Dec; 31(6):685-694. PubMed ID: 28779530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational and Practical Aspects of Drug Repositioning.
    Oprea TI; Overington JP
    Assay Drug Dev Technol; 2015; 13(6):299-306. PubMed ID: 26241209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of academia, rare diseases, and repurposing in the development of the most transformative drugs.
    Kesselheim AS; Tan YT; Avorn J
    Health Aff (Millwood); 2015 Feb; 34(2):286-93. PubMed ID: 25646109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
    Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
    Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
    Padhy BM; Gupta YK
    J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.